- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04234087
Feasibility and Effectiveness of an Additional Resistance and Balance Training in Cardiac Rehabilitation of Older Patients After Valve Surgery or Intervention
July 14, 2020 updated by: Eglė Tamulevičiūtė-Prascienė, Lithuanian University of Health Sciences
The aim of the study is to evaluate the short- and medium-term effectiveness of additional moderate dynamic resistance and balance training to the CR-program of old adults after valve surgery or intervention compared to usual care-CR.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
116
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Kulautuva
-
Kaunas, Kulautuva, Lithuania
- LUHS hospital Kaunas Clinics Rehabilitation hospital of Kulautuva
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
65 years and older (OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Patients after valve surgery and/or intervention
- Age 65 years and older
- Ability to start CR within 4 weeks after surgery,
- 6-minute walk distance (6-MWD) ≥100- ≤350 m (1)
- Patient's agreement to participate in the study.
Exclusion Criteria:
- Diseases in the musculoskeletal system or other organs complicating physical activity and exercise training;
- Exercise-limiting comorbidities (primarily orthopedic and neurological conditions that would exclude individuals from participating in CR according to study protocol), including chronic heart failure New York Heart Association Class IV, hemoglobin less than 9 g/dL, wound healing disturbance, cognitive or linguistic deficits.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
NO_INTERVENTION: Control group
The supervised exercise program included: continues endurance training on cycle ergometers (6 sessions a week).
Every session included warm up (<50% target intensity 2 min, gradually increasing load 1-10 w/min up to target intensity within 5 - 10 min); exercise phase (100% of the target intensity (30-50% watts or 30-50% HRmax), starting with >5 minutes and gradually prolonged up to 30 min); cool down with gradual reduction of the load within 3 minutes); additional aerobic exercises performed sitting and/or standing (30 minutes, 5 days/week); respiratory muscle training (7 days/week, for 15 minutes) using ball trainer.
|
|
OTHER: Intervention group
Exercise program as for a control group together with additional resistance and balance training 3 sessions/week.
The resistance training was started with low intensity (<30% 1-RM, RPE ≤ 11, 5-10 repetitions), increased gradually to moderate intensity (30-50% and up to 60% 1-RM, RPE 12-13, after 8-15 repetitions) with 3 sets and 3 minute rest between sets, if tolerated.
The balance training included exercises to improve static as well as dynamic balance ability.
It was performed on 2-3 days/week for 10-15 minutes.
The complexity of the balance exercises was selected and incremented individually by changing the stand-position, the base on which the stands were performed and/or using unstable surfaces.
If tolerated, the visual information was varied and/or additional tasks performed while balancing.
After completion participants were encouraged to continue exercise training at home according to recommendations.
|
Additional exercise program with balance and resistance training three times per week.
After completion participants are encouraged to continue exercise training at home according to recommendations and will receive control calls every two weeks.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Physical performance by Short Physical Perfromance Battery (SPPB)
Time Frame: Baseline
|
The short physical performance battery (SPPB) is a group of measures that combines the results of the gait speed, chair stand and balance tests.The scores range from 0 (worst performance) to 12 (best performance).
|
Baseline
|
Physical performance by Short Physical Perfromance Battery (SPPB)
Time Frame: 20 days
|
The short physical performance battery (SPPB) is a group of measures that combines the results of the gait speed, chair stand and balance tests.The scores range from 0 (worst performance) to 12 (best performance).
|
20 days
|
Physical performance by Short Physical Perfromance Battery (SPPB)
Time Frame: Three months
|
The short physical performance battery (SPPB) is a group of measures that combines the results of the gait speed, chair stand and balance tests.The scores range from 0 (worst performance) to 12 (best performance).
|
Three months
|
Physical performance by 5 meters walking test (5MWT)
Time Frame: Baseline
|
5MWT is a gate speed test measured by meters per second.
|
Baseline
|
Physical performance by 5 meters walking test (5MWT)
Time Frame: 20 days
|
5MWT is a gate speed test measured by meters per second.
|
20 days
|
Physical performance by 5 meters walking test (5MWT)
Time Frame: 3 months
|
5MWT is a gate speed test measured by meters per second.
|
3 months
|
Functional capacity by six minutes walking test (6MWT)
Time Frame: Baseline
|
6MWT measured by meters
|
Baseline
|
Functional capacity by six minutes walking test (6MWT)
Time Frame: 20 days
|
6MWT measured by meters
|
20 days
|
Functional capacity by six minutes walking test (6MWT)
Time Frame: 3 months
|
6MWT measured by meters
|
3 months
|
Quality of life by questionnaire Short Form Survey SF-36
Time Frame: Baseline
|
0-100%, the higher score, the better quality of life.
The SF-36 measures eight scales: physical functioning (PF), role physical (RP), bodily pain (BP), general health (GH), vitality (VT), social functioning (SF), role emotional (RE), and mental health (MH) in units on the scale
|
Baseline
|
Quality of life by questionnaire Short Form Survey SF-36
Time Frame: 20 days
|
0-100%, the higher score, the better quality of life.
The SF-36 measures eight scales: physical functioning (PF), role physical (RP), bodily pain (BP), general health (GH), vitality (VT), social functioning (SF), role emotional (RE), and mental health (MH) in units on the scale
|
20 days
|
Quality of life by questionnaire Short Form Survey SF-36
Time Frame: 3 months
|
0-100%, the higher score, the better quality of life.
The SF-36 measures eight scales: physical functioning (PF), role physical (RP), bodily pain (BP), general health (GH), vitality (VT), social functioning (SF), role emotional (RE), and mental health (MH) in units on the scale
|
3 months
|
Quality of life by questionnaire Minnesota living with heart failure (Minesota HF)
Time Frame: Baseline
|
Minesota HF questionnaire in units on the scale, 0-105, the the lower score, the better quality of life
|
Baseline
|
Quality of life by questionnaire Minnesota living with heart failure (Minesota HF)
Time Frame: 20 days
|
Minesota HF questionnaire in units on the scale, 0-105, the the lower score, the better quality of life
|
20 days
|
Quality of life by questionnaire Minnesota living with heart failure (Minesota HF)
Time Frame: 3 months
|
Minesota HF questionnaire in units on the scale, 0-105, the the lower score, the better quality of life
|
3 months
|
Quality of life by questionnaire EQ-5D
Time Frame: Baseline
|
EQ-5D in units on the scale, 0-10, the higher score, the better quality of life
|
Baseline
|
Quality of life by questionnaire EQ-5D
Time Frame: 20 days
|
EQ-5D in units on the scale, 0-10, the higher score, the better quality of life
|
20 days
|
Quality of life by questionnaire EQ-5D
Time Frame: 3 months
|
EQ-5D in units on the scale, 0-10, the higher score, the better quality of life
|
3 months
|
Quality of life by questionnaire Quality of Life: Cardiac Index
Time Frame: Baseline
|
Quality of Life: Cardiac Index in units on the scale, 15-33 the higher score, the better quality of life
|
Baseline
|
Quality of life by questionnaire Quality of Life: Cardiac Index
Time Frame: 20 days
|
Quality of Life: Cardiac Index in units on the scale, 15-33 the higher score, the better quality of life
|
20 days
|
Quality of life by questionnaire Quality of Life: Cardiac Index
Time Frame: 3 months
|
Quality of Life: Cardiac Index in units on the scale, 15-33 the higher score, the better quality of life
|
3 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Frailty level by SPPB score
Time Frame: baseline
|
Frailty measured by SPPB score - 0-7 - frail, 8-9 - pre-frail, 10-12 robust.
|
baseline
|
Frailty level by SPPB score
Time Frame: 20 days
|
Frailty measured by SPPB score - 0-7 - frail, 8-9 - pre-frail, 10-12 robust.
|
20 days
|
Frailty level by SPPB score
Time Frame: three months
|
Frailty measured by SPPB score - 0-7 - frail, 8-9 - pre-frail, 10-12 robust.
|
three months
|
Frailty level by 5MWT
Time Frame: baseline
|
Frailty measured by 5MWT - <0,6 m/s - frail, 0,7-0,99 m/s - pre-frail, 1,0 m/s and more - robust
|
baseline
|
Frailty level by 5MWT
Time Frame: 20 days
|
Frailty measured by 5MWT - <0,6 m/s - frail, 0,7-0,99 m/s - pre-frail, 1,0 m/s and more - robust
|
20 days
|
Frailty level by 5MWT
Time Frame: three months
|
Frailty measured by 5MWT - <0,6 m/s - frail, 0,7-0,99 m/s - pre-frail, 1,0 m/s and more - robust
|
three months
|
Physical activity by International physical activity questionnaire (IPAQ)
Time Frame: 3 months
|
IPAQ in units on the scale
|
3 months
|
Physical activity by International physical activity questionnaire (IPAQ)
Time Frame: 20 days
|
IPAQ in units on the scale
|
20 days
|
Physical activity by International physical activity questionnaire (IPAQ)
Time Frame: Baseline
|
IPAQ in units on the scale
|
Baseline
|
Cardiopulmonary exercise capacity by maximal oxygen consumption (peakVO2)
Time Frame: Baseline
|
PeakVO2 measured with spiroergometry by millilitres of oxygen per kilogram of body mass per minute
|
Baseline
|
Cardiopulmonary exercise capacity by maximal load (maxWatt)
Time Frame: Baseline
|
Maximal load measured with spiroergometry by maximal watts
|
Baseline
|
Cardiopulmonary exercise capacity by maximal oxygen consumption (peakVO2)
Time Frame: 20 days
|
PeakVO2 measured with spiroergometry by millilitres of oxygen per kilogram of body mass per minute
|
20 days
|
Cardiopulmonary exercise capacity by maximal oxygen consumption (peakVO2)
Time Frame: 3 months
|
PeakVO2 measured with spiroergometry by millilitres of oxygen per kilogram of body mass per minute
|
3 months
|
Cardiopulmonary exercise capacity by maximal load (maxWatt)
Time Frame: 20 days
|
Maximal load measured with spiroergometry by maximal watts
|
20 days
|
Cardiopulmonary exercise capacity by maximal load (maxWatt)
Time Frame: 3 months
|
Maximal load measured with spiroergometry by maximal watts
|
3 months
|
Muscular strength by one repetition maximum test (1RM)
Time Frame: baseline
|
1RM test for leg extension measured by kilograms
|
baseline
|
Muscular strength by one repetition maximum test (1RM)
Time Frame: 20 days
|
1RM test for leg extension measured by kilograms
|
20 days
|
Muscular strength by one repetition maximum test (1RM)
Time Frame: 3 months
|
1RM test for leg extension measured by kilograms
|
3 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Raimondas Kubilius, Prof, Lithuanian University of Health Sciences, Department of Rehabilitation
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
February 26, 2018
Primary Completion (ACTUAL)
February 1, 2020
Study Completion (ACTUAL)
June 30, 2020
Study Registration Dates
First Submitted
January 12, 2020
First Submitted That Met QC Criteria
January 15, 2020
First Posted (ACTUAL)
January 21, 2020
Study Record Updates
Last Update Posted (ACTUAL)
July 16, 2020
Last Update Submitted That Met QC Criteria
July 14, 2020
Last Verified
July 1, 2020
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- LUHS001
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Quality of Life
-
Assiut UniversityUnknownImproving Quality of LifeEgypt
-
Children's National Research InstituteRecruitingProfessional Quality of LifeUnited States
-
Istituto Ortopedico RizzoliUniversity of BolognaActive, not recruitingImprove Quality of LifeItaly
-
B. Braun Medical SAUnknownQuality of Life of Colostomized Patient
-
Mattu UniversityCompletedBreif Description: Patients' Quality of Life ofEthiopia
-
University of South CarolinaNational Institute on Minority Health and Health Disparities (NIMHD)RecruitingHealth Related Quality of LifeUnited States
-
PharmanexSprim Advanced Life SciencesCompletedHealth-related Quality of LifeUnited States
-
Linkoeping UniversityRecruiting
-
South Valley UniversityActive, not recruitingDeterminants of Health-related Quality of Life for Patients After Renal Lithotripsy: PNL Versus RIRSHealth Related Quality of LifeEgypt
-
Region VästmanlandUnknownHealth Related Quality of Life
Clinical Trials on Additional balance and resistance training
-
Lithuanian University of Health SciencesRecruitingFrailty Syndrome | Ischaemic Heart DiseaseLithuania
-
University of KielCompletedParkinson's Disease
-
Western University, CanadaCompletedCognitive ImpairmentCanada
-
University of British ColumbiaActive, not recruitingMild Cognitive ImpairmentCanada
-
Universidad de ZaragozaUnknownAdolescent Behavior | Executive Function Disorder | Strength Training | Academic AchievementSpain
-
Region SkaneUnknown
-
Riphah International UniversityRecruitingDiabetic Peripheral Neuropathy (DPN)Pakistan
-
Wake Forest UniversityNot yet recruiting
-
Palo Alto Veterans Institute for ResearchUnited States Department of DefenseUnknownDementia | Alzheimer Disease | Head Injury | TBI | Concussion, Brain | Traumas, BrainUnited States